Both Semaglutide and copyright belong to a group of therapies called Glucagon-like Peptide-1 GLP-1 stimulators. These powerful substances operate by mimicking the body's natural hormone , Glucagon-like Peptide-1, to help reduce blood sugar and encourage a decrease in weight. This common mechanism of action explains why such drugs are commonly consi